Results 131 to 140 of about 2,504,313 (305)
This study introduces the Hiki Index (HI), a novel radiographic metric based on upright abdominal X‐rays, to objectively assess postoperative gastric dilatation after gastrectomy. The HI demonstrated strong predictive value for gastrointestinal symptoms and the need for therapeutic intervention, offering a practical tool for early detection and ...
Hiroki Harada +9 more
wiley +1 more source
List of executive managers of Russian association of endocrinologists
Editorial team Diabetes Mellitus
doaj +1 more source
ABSTRACT Aim The prognostic immune nutritional index (PINI) is increasingly recognized for its potential clinical utility. However, multifaceted evaluations of its ability to predict oncological outcomes in colorectal cancer (CRC) and its association with postoperative infectious complications remain limited.
Shinji Yamashita +9 more
wiley +1 more source
This multicenter study suggests that adjuvant chemotherapy may improve survival in stage IV intrahepatic cholangiocarcinoma after resection, with S‐1 showing a potential survival advantage. ABSTRACT Background The survival benefit of adjuvant chemotherapy (AC) in intrahepatic cholangiocarcinoma (ICC) remains uncertain, particularly in advanced‐stage ...
Hisashi Kosaka +9 more
wiley +1 more source
Galvus and Galvus Met, new registered medicinal agents for the treatment of diabetes mellitus
Editorial team Diabetes Mellitus
doaj +1 more source
Trends in mortality related to kidney failure and diabetes mellitus in the United States: a 1999–2020 analysis [PDF]
Ahmed Mustafa Rashid +15 more
openalex +1 more source
This report details a modified reconstructive technique, longitudinal pancreaticojejunostomy (LPJ), following pancreaticoduodenectomy (PD) for patients with both pancreatic head pathology and extensive chronic pancreatitis. This approach ensures wide‐area drainage of the remnant pancreatic duct, providing effective symptom relief and preserving long ...
Hideaki Sato +4 more
wiley +1 more source
ABSTRACT Background Nivolumab‐including chemotherapy (nivo‐CTX) for stage IV gastric cancer (GC) may increase the chance of conversion surgery but risk of immune‐related adverse events (irAEs) during perioperative period remains unclear. Methods We examined irAEs in 36 patients with marginally resectable GC who received nivo‐CTX followed by surgery ...
Masashi Nishino +11 more
wiley +1 more source

